Haas Jason

CIK 00018838212 companiesJUPITER, FL

SEC Profile

Transactions

Companies

Filings

CIK

0001883821

Recent Transactions

32 trades

Award
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2025-06-06+1,209→ 6,606 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2025-06-06+5,783→ 5,783 total
Sale
Syros Pharmaceuticals, Inc.
Common Stock
2024-11-18$0.21/sh−137,803→ 0 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2024-10-31−18,875→ 0 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Common Stock
2024-10-31+18,875→ 143,427 total
Tax Payment
Syros Pharmaceuticals, Inc.
Common Stock
2024-10-31$2.09/sh−5,624→ 137,803 total
Purchase
Syros Pharmaceuticals, Inc.
Common Stock
2024-09-12$1.68/sh+45,344→ 124,552 total
Purchase
Syros Pharmaceuticals, Inc.
Common Stock
2024-09-11$1.58/sh+19,293→ 79,208 total
Purchase
Syros Pharmaceuticals, Inc.
Common Stock
2024-09-10$1.55/sh+35,363→ 59,915 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2024-06-14+1,252→ 5,397 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2024-06-14+5,444→ 5,444 total
Tax Payment
Syros Pharmaceuticals, Inc.
Common Stock
2024-04-01$5.12/sh−4,732→ 24,552 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Common Stock
2024-03-31+2,000→ 15,951 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2024-03-31−13,333→ 26,667 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2024-03-31−2,000→ 4,000 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Common Stock
2024-03-31+13,333→ 29,284 total
Tax Payment
Syros Pharmaceuticals, Inc.
Common Stock
2023-11-01$2.22/sh−6,301→ 13,951 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Common Stock
2023-10-31+18,875→ 20,252 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2023-10-31−18,875→ 18,875 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2023-06-09+1,142→ 4,145 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2023-06-09+5,461→ 5,461 total
Tax Payment
Syros Pharmaceuticals, Inc.
Common Stock
2023-04-03$2.58/sh−623→ 1,377 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Common Stock
2023-03-31+2,000→ 2,000 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2023-03-31−2,000→ 6,000 total
Award
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2023-02-16+40,000→ 40,000 total
Award
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2022-10-06+37,750→ 37,750 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2022-10-06+49,750→ 49,750 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2022-06-29+1,750→ 1,750 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2022-06-29+5,907→ 5,907 total
Award
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2022-02-15+80,000→ 80,000 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2022-02-15+125,000→ 125,000 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2021-10-12+750,000→ 750,000 total

Companies

Recent Filings

Address

555 HERITAGE DRIVE SUITE 200

JUPITER, FL, 33458

View on SEC.gov